SIM
CVS icon

Studio Investment Management’s CVS Health CVS Stock Holding History

Studio Investment Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-364
Closed -$24.7K – 200
2025
Q1 		$24.7K Sell
364
-5,812
-94% -$348K 0.01% 228
2024
Q4 		$277K Sell
6,176
-5,636
-48% -$316K 0.06% 150
2024
Q3 		$743K Sell
11,812
-61
-0.5% -$3.56K 0.16% 90
2024
Q2 		$701K Buy
11,873
+1,791
+18% +$112K 0.16% 88
2024
Q1 		$804K Sell
10,082
-24,381
-71% -$1.86M 0.19% 80
2023
Q4 		$2.72M Buy
34,463
+3,936
+13% +$280K 0.69% 44
2023
Q3 		$2.13M Buy
30,527
+6,199
+25% +$439K 0.6% 44
2023
Q2 		$1.68M Buy
24,328
+3,600
+17% +$256K 0.47% 58
2023
Q1 		$1.54M Buy
20,728
+124
+0.6% +$10.4K 0.47% 54
2022
Q4 		$1.92M Sell
20,604
-246
-1% -$23.7K 0.62% 49
2022
Q3 		$1.99M Sell
20,850
-955
-4% -$94.5K 0.72% 43
2022
Q2 		$2.02M Sell
21,805
-450
-2% -$43.9K 0.7% 46
2022
Q1 		$2.25M Sell
22,255
-5,655
-20% -$594K 0.74% 49
2021
Q4 		$2.88M Sell
27,910
-6,855
-20% -$633K 1.04% 28
2021
Q3 		$2.95M Buy
+34,765
New +$2.91M 1.26% 23

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Studio Investment Management's CVS Position: Q2 2025 in Review

Studio Investment Management sold out of CVS Health (CVS) in Q2 2025, closing a stake of 364 shares — an estimated $24.7K sold.

Studio Investment Management first reported a position in CVS in Q3 2021 and held it in 15 quarters. The position peaked at $2.95M in Q3 2021. 1,759 funds tracked by Wall St. Rank hold CVS as of Q2 2025.

  • Studio Investment Management reported no remaining CVS Health position as of Q2 2025 after selling out during the quarter.
  • Studio Investment Management sold 364 CVS Health shares in Q2 2025, an estimated $24.7K.
  • Studio Investment Management first reported a position in CVS Health in Q3 2021 and held it in 15 quarters.
  • Studio Investment Management's CVS Health position peaked at $2.95M in Q3 2021.
  • 1,759 funds tracked by Wall St. Rank held CVS Health as of Q2 2025.

Based on Studio Investment Management's 13F filing for Q2 2025, filed 30 Jul 2025.